BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11469676)

  • 1. The physiological estrogen metabolite 2-methoxyestradiol reduces tumor growth and induces apoptosis in human solid tumors.
    Schumacher G; Neuhaus P
    J Cancer Res Clin Oncol; 2001 Jul; 127(7):405-10. PubMed ID: 11469676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [2-Methoxyestradiol -- a new compound for cancer treatment].
    Schumacher G; Neuhaus P
    Dtsch Med Wochenschr; 2006 Apr; 131(15):825-30. PubMed ID: 16607604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of 2-methoxyestradiol liposome on growth inhibition, angiogenesis and expression of VEGF and Ki67 in mice bearing H22 hepatocellular carcinoma.
    Du B; Wang SY; Shi XF; Zhang CF; Zhang ZZ
    Tumori; 2011; 97(5):660-5. PubMed ID: 22158500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-Methoxyestradiol: an endogenous antiangiogenic and antiproliferative drug candidate.
    Pribluda VS; Gubish ER; Lavallee TM; Treston A; Swartz GM; Green SJ
    Cancer Metastasis Rev; 2000; 19(1-2):173-9. PubMed ID: 11191057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-Methoxyestradiol inhibits hepatocellular carcinoma cell growth by inhibiting Cdc25 and inducing cell cycle arrest and apoptosis.
    Kar S; Wang M; Carr BI
    Cancer Chemother Pharmacol; 2008 Oct; 62(5):831-40. PubMed ID: 18246350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and Pharmacological Effects of the Anti-Cancer Agent 2-Methoxyestradiol.
    Solum EJ; Akselsen ØW; Vik A; Hansen TV
    Curr Pharm Des; 2015; 21(38):5453-66. PubMed ID: 26429718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic promises of 2-methoxyestradiol and its drug disposition challenges.
    Verenich S; Gerk PM
    Mol Pharm; 2010 Dec; 7(6):2030-9. PubMed ID: 20831190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-methoxyestradiol induces interferon gene expression and apoptosis in osteosarcoma cells.
    Maran A; Zhang M; Kennedy AM; Sibonga JD; Rickard DJ; Spelsberg TC; Turner RT
    Bone; 2002 Feb; 30(2):393-8. PubMed ID: 11856647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-Methoxyestradiol, an endogenous estrogen metabolite, induces thyroid cell apoptosis.
    Wang SH; Myc A; Koenig RJ; Bretz JD; Arscott PL; Baker JR
    Mol Cell Endocrinol; 2000 Jul; 165(1-2):163-72. PubMed ID: 10940494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol.
    Klauber N; Parangi S; Flynn E; Hamel E; D'Amato RJ
    Cancer Res; 1997 Jan; 57(1):81-6. PubMed ID: 8988045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential vascular actions of 2-methoxyestradiol.
    Dubey RK; Jackson EK
    Trends Endocrinol Metab; 2009 Oct; 20(8):374-9. PubMed ID: 19734053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-Methoxyestradiol induces G2/M arrest and apoptosis in prostate cancer.
    Qadan LR; Perez-Stable CM; Anderson C; D'Ippolito G; Herron A; Howard GA; Roos BA
    Biochem Biophys Res Commun; 2001 Aug; 285(5):1259-66. PubMed ID: 11478793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral administration of an estrogen metabolite-induced potentiation of radiation antitumor effects in presence of wild-type p53 in non-small-cell lung cancer.
    Huober JB; Nakamura S; Meyn R; Roth JA; Mukhopadhyay T
    Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1127-37. PubMed ID: 11072172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms for 2-methoxyestradiol-induced apoptosis of prostate cancer cells.
    Bu S; Blaukat A; Fu X; Heldin NE; Landström M
    FEBS Lett; 2002 Nov; 531(2):141-51. PubMed ID: 12417302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-Methoxymethylestradiol: a new 2-methoxy estrogen analog that exhibits antiproliferative activity and alters tubulin dynamics.
    Brueggemeier RW; Bhat AS; Lovely CJ; Coughenour HD; Joomprabutra S; Weitzel DH; Vandre DD; Yusuf F; Burak WE
    J Steroid Biochem Mol Biol; 2001 Aug; 78(2):145-56. PubMed ID: 11566439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of radiation effects in vitro by the estrogen metabolite 2-methoxyestradiol.
    Amorino GP; Freeman ML; Choy H
    Radiat Res; 2000 Apr; 153(4):384-91. PubMed ID: 10760997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis?
    Zhu BT; Conney AH
    Cancer Res; 1998 Jun; 58(11):2269-77. PubMed ID: 9622057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-Methoxyestradiol-induced caspase-3 activation and apoptosis occurs through G(2)/M arrest dependent and independent pathways in gastric carcinoma cells.
    Lin HL; Liu TY; Wu CW; Chi CW
    Cancer; 2001 Aug; 92(3):500-9. PubMed ID: 11505393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of action of 2-methoxyestradiol: new developments.
    Mooberry SL
    Drug Resist Updat; 2003 Dec; 6(6):355-61. PubMed ID: 14744499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-methoxyestradiol strongly inhibits human uterine sarcomatous cell growth.
    Amant F; Lottering ML; Joubert A; Thaver V; Vergote I; Lindeque BG
    Gynecol Oncol; 2003 Nov; 91(2):299-308. PubMed ID: 14599859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.